Funded Tech Companies
Bridge Biotherapeutics
Headquartered in Seongnam-si, Gyeonggi-do, Bridge Biotherapeutics has funding from Parataxis Capital.
Company Overview
Company Name
Bridge Biotherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
C's Tower, 58, Pangyo-ro 255 beon-gil, Bundang-gu 303
Seongnam-si, Gyeonggi-do, 13486
South Korea
Seongnam-si, Gyeonggi-do, 13486
South Korea
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Bridge Biotherapeutics is a publicly listed, clinical stage biotech company, founded in 2015 and headquartered in the Republic of Korea. We are highly committed to restoring and improving the lives of patients by developing novel compounds into innovative new drugs through rigorous global clinical development processes.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/20/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Lee
Company Investors
Browse more funded tech companies:
Bridge | Bridge Capital Solutions
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs